Wells Fargo’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.68M | Sell |
73,652
-65,809
| -47% | -$2.94M | ﹤0.01% | 3047 |
|
|
2025
Q4 | $6.49M | Buy |
139,461
+40,759
| +41% | +$1.81M | ﹤0.01% | 2425 |
|
|
2025
Q3 | $4.11M | Buy |
98,702
+8,642
| +10% | +$276K | ﹤0.01% | 2732 |
|
|
2025
Q2 | $2.59M | Sell |
90,060
-1,434
| -2% | -$44.3K | ﹤0.01% | 3008 |
|
|
2025
Q1 | $3.07M | Sell |
91,494
-9,422
| -9% | -$352K | ﹤0.01% | 2804 |
|
|
2024
Q4 | $5.16M | Buy |
100,916
+16,025
| +19% | +$897K | ﹤0.01% | 2420 |
|
|
2024
Q3 | $4.34M | Buy |
84,891
+11,971
| +16% | +$617K | ﹤0.01% | 2453 |
|
|
2024
Q2 | $3.27M | Buy |
72,920
+4,080
| +6% | +$188K | ﹤0.01% | 2583 |
|
|
2024
Q1 | $3.22M | Buy |
68,840
+47,898
| +229% | +$1.87M | ﹤0.01% | 2599 |
|
|
2023
Q4 | $745K | Sell |
20,942
-30,850
| -60% | -$946K | ﹤0.01% | 3617 |
|
|
2023
Q3 | $1.54M | Buy |
51,792
+7,657
| +17% | +$158K | ﹤0.01% | 2999 |
|
|
2023
Q2 | $795K | Buy |
44,135
+13,151
| +42% | +$262K | ﹤0.01% | 3623 |
|
|
2023
Q1 | $498K | Buy |
30,984
+30,567
| +7,330% | +$566K | ﹤0.01% | 3855 |
|
|
2022
Q4 | $7.63K | Sell |
417
-559
| -57% | -$9.85K | ﹤0.01% | 5651 |
|
|
2022
Q3 | $19K | Sell |
976
-545
| -36% | -$11.1K | ﹤0.01% | 5416 |
|
|
2022
Q2 | $27K | Sell |
1,521
-4,635
| -75% | -$92.5K | ﹤0.01% | 5292 |
|
|
2022
Q1 | $135K | Sell |
6,156
-15,959
| -72% | -$323K | ﹤0.01% | 5182 |
|
|
2021
Q4 | $628K | Buy |
+22,115
| New | +$545K | ﹤0.01% | 4481 |
|
|
2021
Q2 | – | Sell |
-5,195
| Closed | -$79K | – | 6956 |
|
|
2021
Q1 | $79K | Sell |
5,195
-17,998
| -78% | -$279K | ﹤0.01% | 5587 |
|
|
2020
Q4 | $327K | Buy |
23,193
+3,354
| +17% | +$46.7K | ﹤0.01% | 4820 |
|
|
2020
Q3 | $311K | Sell |
19,839
-417
| -2% | -$6.37K | ﹤0.01% | 4688 |
|
|
2020
Q2 | $355K | Buy |
20,256
+13,497
| +200% | +$230K | ﹤0.01% | 4561 |
|
|
2020
Q1 | $99K | Sell |
6,759
-2,516
| -27% | -$51.6K | ﹤0.01% | 5062 |
|
|
2019
Q4 | $232K | Sell |
9,275
-14,034
| -60% | -$267K | ﹤0.01% | 4862 |
|
|
2019
Q3 | $351K | Buy |
23,309
+3,110
| +15% | +$60.5K | ﹤0.01% | 4610 |
|
|
2019
Q2 | $505K | Buy |
20,199
+9,999
| +98% | +$248K | ﹤0.01% | 4372 |
|
|
2019
Q1 | $232K | Buy |
10,200
+95
| +0.9% | +$2.33K | ﹤0.01% | 4744 |
|
|
2018
Q4 | $303K | Buy |
10,105
+6,720
| +199% | +$189K | ﹤0.01% | 4664 |
|
|
2018
Q3 | $97K | Buy |
+3,385
| New | +$101K | ﹤0.01% | 5368 |
|
Other funds holding CRNX
FCM
DCM
VCM
VPM
EC